Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

casirivimab and imdevimab drug combination MeSH Supplementary Concept Data 2025


MeSH Supplementary
casirivimab and imdevimab drug combination
Unique ID
C000711751
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000711751
Entry Term(s)
REGEN-COV
REGN-COV
REGN-COV-2
REGN-COV2
REGN10987 and REGN10933 mixture
Ronapreve
Ronpreve
casirivimab and imdevimab
casirivimab plus imdevimab
casirivimab, imdevimab drug combination
casirivimab-imdevimab
Pharm Action
Antiviral Agents
Registry Numbers
0
Heading Mapped to
Drug Combinations
*Antibodies, Neutralizing
*Antibodies, Monoclonal, Humanized
Frequency
56
Note
a mixture of anti-SARS-Cov-2 antibodies
Date of Entry
2020/12/14
Revision Date
2022/01/26
casirivimab and imdevimab drug combination Preferred
REGN-COV-2 Narrower
REGEN-COV Narrower
page delivered in 0.005s